The DOI matches its Crossref record; 641 of the 641 references it cites were found in a registry or an index.
The Treatment of Cushing's Disease
Open accessAbstract
Cushing's disease (CD), or pituitary-dependent Cushing's syndrome, is a severe endocrine disease caused by a corticotroph pituitary tumor and associated with increased morbidity and mortality. The first-line treatment for CD is pituitary surgery, which is followed by disease remission in around 78% and relapse in around 13% of patients during the 10-year period after surgery, so that nearly one third of patients experience in the long-term a failure of surgery and require an additional second-line treatment. Patients with persistent or recurrent CD require additional treatments, including pituitary radiotherapy, adrenal surgery, and/or medical therapy. Pituitary radiotherapy is effective in controlling cortisol excess in a large percentage of patients, but it is associated with a considerable risk of hypopituitarism. Adrenal surgery is followed by a rapid and definitive control of cortisol excess in nearly all patients, but it induces adrenal insufficiency. Medical therapy has recently acquired a more important role compared to the past, due to the recent employment of novel compounds able to control cortisol secretion or action. Currently, medical therapy is used as a presurgical treatment, particularly for severe disease; or as postsurgical treatment, in cases of failure or incomplete surgical tumor resection; or as bridging therapy before, during, and after radiotherapy while waiting for disease control; or, in selected cases, as primary therapy, mainly when surgery is not an option. The adrenal-directed drug ketoconazole is the most commonly used drug, mainly because of its rapid action, whereas the glucocorticoid receptor antagonist, mifepristone, is highly effective in controlling clinical comorbidities, mainly glucose intolerance, thus being a useful treatment for CD when it is associated with diabetes mellitus. Pituitary-directed drugs have the advantage of acting at the site responsible for CD, the pituitary tumor. Among this group of drugs, the dopamine agonist cabergoline and the somatostatin analog pasireotide result in disease remission in a consistent subgroup of patients with CD. Recently, pasireotide has been approved for the treatment of CD when surgery has failed or when surgery is not an option, and mifepristone has been approved for the treatment of Cushing's syndrome when associated with impairment of glucose metabolism in case of the lack of a surgical indication. Recent experience suggests that the combination of different drugs may be able to control cortisol excess in a great majority of patients with CD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meijer, L., Nelson, D. J., Riazanski, V., Gabdoulkhakova, A. G., Hery-Arnaud, G., Le Berre, R., Loaëc, N., Oumata, N., Galons, H., Nowak, E., et al. (2016) · Journal of Innate Immunity · doi:10.1159/000444256 · Cited by 4,992
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
Issemann, I., & Green, S. (1990) · Nature · doi:10.1038/347645a0 · Cited by 3,519
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718
The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated Inflammation
Chrousos, G. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322008 · Cited by 2,579
Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Somatostatin and Its Receptor Family
Patel, Y. C. (1999) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1999.0183 · Cited by 1,648
Metabolic syndrome: definitions and controversies
Kassi, E., Pervanidou, P., Kaltsas, G., & Chrousos, G. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-48 · Cited by 1,565
Lehrke, M., & Lazar, M. A. (2005) · Cell · doi:10.1016/j.cell.2005.11.026 · Cited by 1,443
Diagnosis and complications of Cushing’s syndrome: a consensus statement
Arnaldi, G., Angeli, A., Atkinson, A. B., Bertagna, X., Cavagnini, F., Chrousos, G. P., Fava, G. A., Findling, J. W., Gaillard, R. C., Grossman, A. B., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030871 · Cited by 1,362
Newell-Price, J., Bertagna, X., Grossman, A. B., & Nieman, L. K. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68699-6 · Cited by 1,165
Sarcoma in irradiated bone. Report of eleven cases
Cahan, W. G., Woodard, H. Q., Higinbotham, N. L., Stewart, F. W., & Coley, B. L. (1948) · Cancer · doi:10.1002/1097-0142(194805)1:1<3::aid-cncr2820010103>3.0.co;2-7 · Cited by 1,095
Ciric, I., Ragin, A., Baumgartner, C., & Pierce, D. (1997) · Neurosurgery · doi:10.1097/00006123-199702000-00001 · Cited by 1,029
Valvular Heart Disease and the Use of Dopamine Agonists for Parkinson's Disease
Zanettini, R., Antonini, A., Gatto, G., Gentile, R., Tesei, S., & Pezzoli, G. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa054830 · Cited by 884
Treatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement
Biller, B. M. K., Grossman, A. B., Stewart, P. M., Melmed, S., Bertagna, X., Bertherat, J., Buchfelder, M., Colao, A., Hermus, A. R., Hofland, L. J., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2734 · Cited by 853
Self-citationThe Diagnosis and Differential Diagnosis of Cushing’s Syndrome and Pseudo-Cushing’s States
Newell-Price, J., Trainer, P., Besser, M., & Grossman, A. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.5.0346 · Cited by 833
CENTRAL OBESITY AND CORONARY HEART DISEASE IN MEN
Donahue, R., & Abbott, R. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91357-2 · Cited by 818
Silverman, M. N., & Sternberg, E. M. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06633.x · Cited by 731
Dopamine Agonists and the Risk of Cardiac-Valve Regurgitation
Schade, R., Andersohn, F., Suissa, S., Haverkamp, W., & Garbe, E. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa062222 · Cited by 718
Glucocorticoids and invasive fungal infections
Lionakis, M. S., & Kontoyiannis, D. P. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14904-5 · Cited by 669
Charmandari, E., Nicolaides, N. C., & Chrousos, G. P. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61684-0 · Cited by 644
Transphenoidal Microsurgery of the Normal and Pathological Pituitary: Chapter X
Hardy, J. (1969) · Neurosurgery · doi:10.1093/neurosurgery/16.cn_suppl_1.185 · Cited by 640
A 12-month phase 3 study of pasireotide in Cushing's disease
Colao, A., Petersenn, S., Newell-Price, J., Findling, J. W., Gu, F., Maldonado, M., Schoenherr, U., Dipl.-Biol., Mills, D., Salgado, L. R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1105743 · Cited by 628
Self-citationMorbidity and mortality in Cushing's disease: an epidemiological approach.
Etxabe, J., & Vazquez, J. A. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02486.x · Cited by 622
Incidence and Late Prognosis of Cushing’s Syndrome: A Population-Based Study1
Lindholm, J., Juul, S., Jørgensen, J. O. L., Astrup, J., Bjerre, P., Feldt-Rasmussen, U., Hagen, C., Jørgensen, J., Kosteljanetz, M., Kristensen, L. Ø., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7093 · Cited by 619
Chatzellis, E., Alexandraki, K. I., Androulakis, I. I., & Kaltsas, G. (2015) · Neuroendocrinology · doi:10.1159/000371806 · Cited by 572
Inhibition of Adrenal Steroidogenesis by the Anesthetic Etomidate
Wagner, R. L., White, P. F., Kan, P. B., Rosenthal, M. H., & Feldman, D. (1984) · New England Journal of Medicine · doi:10.1056/nejm198405313102202 · Cited by 555
Leber, K. A., Berglöff, J., & Pendl, G. (1998) · Journal of Neurosurgery · doi:10.3171/jns.1998.88.1.0043 · Cited by 513
Incidence and Late Prognosis of Cushing's Syndrome: A Population-Based Study
Lindholm, J. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.1.117 · Cited by 507
Barker, F. G., Klibanski, A., & Swearingen, B. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030461 · Cited by 506
Tolerance of cranial nerves of the cavernous sinus to radiosurgery
Tishler, R. B., Loeffler, J. S., Lunsford, L. D., Duma, C., Alexander, E., Kooy, H. M., & Flickinger, J. C. (1993) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(93)90230-s · Cited by 486
Fleseriu, M., Biller, B. M. K., Findling, J. W., Molitch, M. E., Schteingart, D. E., Gross, C., on behalf of the SEISMIC Study Investigators, The SEISMIC Study Investigators include, Auchus, R., Bailey, T., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3350 · Cited by 479
Dopamine Agonists and Pituitary Tumor Shrinkage
BEVAN, J. S., WEBSTER, J., Burke, C. W., & Scanlon, M. F. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-2-220 · Cited by 469
Colao, A. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.8.2664 · Cited by 450
Self-citationKetoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes.
Loose, D. S., Kan, P. B., Hirst, M. A., Marcus, R. A., & Feldman, D. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110903 · Cited by 443
Cushing's syndrome in children and adolescents. Presentation, diagnosis, and therapy.
Magiakou, M. A., Mastorakos, G., Oldfield, E. H., Gomez, M. T., Doppman, J. L., Cutler, G. B., Nieman, L. K., & Chrousos, G. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409083311002 · Cited by 430
RU486 (MIFEPRISTONE): Mechanisms of Action and Clinical Uses
Cadepond, P., Ulmann, M., & Baulieu, M. (1997) · Annual Review of Medicine · doi:10.1146/annurev.med.48.1.129 · Cited by 424
Ketoconazole Blocks Adrenal Steroid Synthesis
PONT, A., WILLIAMS, P. L., LOOSE, D. S., FELDMAN, D., REITZ, R. E., BOCHRA, C., & STEVENS, D. A. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-3-370 · Cited by 422
Multisystem morbidity and mortality in Cushing’s syndrome: a cohort study
Dekkers, O. M., Horváth-Puhó, E., Jørgensen, J. O. L., Cannegieter, S. C., Ehrenstein, V., Vandenbroucke, J. P., Pereira, A. M., & Sørensen, H. T. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3582 · Cited by 419
Change in Neurocognitive Functioning After Treatment With Cranial Radiation in Childhood
Spiegler, B. J., Bouffet, E., Greenberg, M. L., Rutka, J. T., & Mabbott, D. J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.186 · Cited by 409
Dehdashti, A. R., Ganna, A., Karabatsou, K., & Gentili, F. (2008) · Neurosurgery · doi:10.1227/01.neu.0000297072.75304.89 · Cited by 408
The use of ketoconazole as an inhibitor of steroid production
Oates, J. A., Wood, A. J. J., & Sonino, N. (1987) · New England Journal of Medicine · doi:10.1056/nejm198709243171307 · Cited by 395
Hepatic Injury Associated With Ketoconazole Therapy
Lewis, J. H., Zimmerman, H. J., Benson, G. D., & Ishak, K. G. (1984) · Gastroenterology · doi:10.1016/s0016-5085(84)80021-9 · Cited by 394
Transsphenoidal Microsurgery for Cushing Disease: A Report of 216 Cases
Mampalam, T. J., Tyrrell, J. B., & Wilson, C. B. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-6-487 · Cited by 386
Caron, M. G., Beaulieu, M., Raymond, V., Gagné, B., Drouin, J., Lefkowitz, R. J., & Labrie, F. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38065-1 · Cited by 383
Retinoid X receptor-COUP-TF interactions modulate retinoic acid signaling.
Kliewer, S. A., Umesono, K., Heyman, R. A., Mangelsdorf, D. J., Dyck, J. A., & Evans, R. M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.4.1448 · Cited by 383
Estrada, J., Boronat, M., Mielgo, M., Magallón, R., Millán, I., Díez, S., Lucas, T., & Barceló, B. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701163360303 · Cited by 383
Minniti, G., Traish, D., Ashley, S., Gonsalves, A., & Brada, M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1152 · Cited by 377
Clayton, R. N., Raskauskiene, D., Reulen, R. C., & Jones, P. W. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1942 · Cited by 374
Transsphenoidal Microsurgery for Cushing’s Disease: Initial Outcome and Long-Term Results
Hammer, G. D., Tyrrell, J. B., Lamborn, K. R., Applebury, C. B., Hannegan, E. T., Bell, S., Rahl, R., Lu, A., & Wilson, C. B. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032180 · Cited by 374
Novel Dimeric Nur77 Signaling Mechanism in Endocrine and Lymphoid Cells
Philips, A., Lesage, S., Gingras, R., Maira, M.-H., Gauthier, Y., Hugo, P., & Drouin, J. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.10.5946 · Cited by 372
The long‐term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas
Brada, M., Rajan, B., Traish, D., Ashley, S., Holmes‐Sellors, P. J., Nussey, S., & Uttley, D. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb02137.x · Cited by 370
CANDIA, S. D. (1951) · PubMed · Cited by 365
DEATH DURING THERAPEUTIC STARVATION
Hermann, L. S., & Iversen, M. (1968) · The Lancet · doi:10.1016/s0140-6736(68)92649-4 · Cited by 361
Clinical and Molecular Pharmacology of Etomidate
Forman, S. A., & Warner, D. S. (2011) · Anesthesiology · doi:10.1097/aln.0b013e3181ff72b5 · Cited by 361
Faggiano, A., Pivonello, R., Spiezia, S., De Martino, M. C., Filippella, M., Di Somma, C., Lombardi, G., & Colao, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021558 · Cited by 358
Self-citationA study on the radiation tolerance of the optic nerves and chiasm after stereotactic radiosurgery
Stafford, S. L., Pollock, B. E., Leavitt, J. A., Foote, R. L., Brown, P. D., Link, M. J., Gorman, D. A., & Schomberg, P. J. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)04380-8 · Cited by 355
Regulation of prolactin secretion at the level of the lactotroph
Lamberts, S. W., & Macleod, R. M. (1990) · Physiological Reviews · doi:10.1152/physrev.1990.70.2.279 · Cited by 353
Packer, R. J., Sutton, L. N., Atkins, T. E., Radcliffe, J., Bunin, G. R., D'Angio, G., Siegel, K. R., & Schut, L. (1989) · Journal of Neurosurgery · doi:10.3171/jns.1989.70.5.0707 · Cited by 351
Ketoconazole blocks testosterone synthesis
Pont, A. (1982) · Archives of Internal Medicine · doi:10.1001/archinte.142.12.2137 · Cited by 350
Bochicchio, D. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.11.3114 · Cited by 344
Cushing’s Syndrome during Pregnancy: Personal Experience and Review of the Literature
Lindsay, J. R., Jonklaas, J., Oldfield, E. H., & Nieman, L. K. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2361 · Cited by 343
Endoscopic Endonasal Transsphenoidal Approach: Outcome Analysis of 100 Consecutive Procedures
Cappabianca, P., Cavallo, L. M., Colao, A., Del Basso De Caro, M., Esposito, F., Cirillo, S., Lombardi, G., & de Divitiis, E. (2002) · min - Minimally Invasive Neurosurgery · doi:10.1055/s-2002-36197 · Cited by 343
Self-citationDiagnosis and Management of Cushing’s Syndrome: Results of an Italian Multicentre Study 1
Invitti, C., Giraldi, F. P., De Martin, M., & Cavagnini, F. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5465 · Cited by 336
Pivonello, R., De Martino, M. C., Cappabianca, P., De Leo, M., Faggiano, A., Lombardi, G., Hofland, L. J., Lamberts, S. W. J., & Colao, A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1533 · Cited by 328
Self-citationResults of Treatment in 108 Patients with Cushing's Syndrome
Orth, D. N., & Liddle, G. W. (1971) · New England Journal of Medicine · doi:10.1056/nejm197107292850501 · Cited by 326
Late Recurrences of Cushing’s Disease after Initial Successful Transsphenoidal Surgery
Patil, C. G., Prevedello, D. M., Lad, S. P., Vance, M. L., Thorner, M. O., Katznelson, L., & Laws, E. R. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2013 · Cited by 320
Successful Treatment of Cushing’s Syndrome with the Glucocorticoid Antagonist RU 486*
NIEMAN, L. K., CHROUSOS, G. P., KELLNER, C., SPITZ, I. M., NISULA, B. C., CUTLER, G. B., MERRIAM, G. R., BARDIN, C. W., & LORIAUX, D. L. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-61-3-536 · Cited by 317
Cyproheptadine-Induced Remission of Cushing's Disease
Krieger, D. T., Amorosa, L., & Linick, F. (1975) · New England Journal of Medicine · doi:10.1056/nejm197510302931802 · Cited by 316
Verhelst, J. A., Trainer, P. J., Howlett, T. A., Perry, L., Rees, L. H., Grossman, A. B., Wass, J. A. H., & Sesser, G. M. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb03517.x · Cited by 308
Assalia, A., & Gagner, M. (2004) · British Journal of Surgery · doi:10.1002/bjs.4738 · Cited by 308
The Endoscopic versus the Traditional Approach in Pituitary Surgery
Frank, G., Pasquini, E., Farneti, G., Mazzatenta, D., Sciarretta, V., Grasso, V., & Faustini Fustini, M. (2006) · Neuroendocrinology · doi:10.1159/000095534 · Cited by 306
Ammirati, M., Wei, L., & Ciric, I. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303194 · Cited by 302
Cushing's Disease: Selective trans-Sphenoidal Resection of Pituitary Microadenomas
Tyrrell, J. B., Brooks, R. M., Fitzgerald, P. A., Cofoid, P. B., Forsham, P. H., & Wilson, C. B. (1978) · New England Journal of Medicine · doi:10.1056/nejm197804062981401 · Cited by 300
Ketoconazole Blocks Testosterone Synthesis
Pont, A. (1982) · Archives of Internal Medicine · doi:10.1001/archinte.1982.00340250097015 · Cited by 296
Cushing’s Syndrome: important issues in diagnosis and management
Findling, J. W., & Raff, H. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0997 · Cited by 294
Starkman, M. N., Schteingart, D. E., & Schork, A. M. (1981) · Psychosomatic Medicine · doi:10.1097/00006842-198102000-00002 · Cited by 289
Ketoconazole in Cushing's disease: is it worth a try?
Castinetti, F., Guignat, L., Giraud, P., Muller, M., Kamenicky, P., Drui, D., Caron, P., Luca, F., Donadille, B., Vantyghem, M. C., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3628 · Cited by 285
Berker, M., Hazer, D. B., Yücel, T., Gürlek, A., Cila, A., Aldur, M., & Önerci, M. (2012) · Pituitary · doi:10.1007/s11102-011-0368-2 · Cited by 282
Endoscopic transsphenoidal surgery
Jho, H.-D. (2001) · Journal of Neuro-Oncology · doi:10.1023/a:1012969719503 · Cited by 280
Visual Complications following Irradiation for Pituitary Adenomas and Craniopharyngiomas
Harris, J. R., & Levene, M. B. (1976) · Radiology · doi:10.1148/120.1.167 · Cited by 279
Boscaro, M., Ludlam, W. H., Atkinson, B., Glusman, J. E., Petersenn, S., Reincke, M., Snyder, P., Tabarin, A., Biller, B. M. K., Findling, J., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1008 · Cited by 279
High cardiovascular risk in patients with Cushing’s syndrome according to 1999 WHO/ISH guidelines
Mancini, T., Kola, B., Mantero, F., Boscaro, M., & Arnaldi, G. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02168.x · Cited by 278
Hofland, L. J., van der Hoek, J., Feelders, R., van Aken, M. O., van Koetsveld, P. M., Waaijers, M., Sprij-Mooij, D., Bruns, C., Weckbecker, G., de Herder, W. W., et al. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01876 · Cited by 276
RADIATION‐INDUCED HYPOPITUITARISM IS DOSE‐DEPENDENT
LITTLEY, M. D., SHALET, S. M., BEARDWELL, C. G., ROBINSON, E. L., & SUTTON, M. L. (1989) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1989.tb01260.x · Cited by 273
Dopamine Receptor Expression and Function in Corticotroph Pituitary Tumors
Pivonello, R., Ferone, D., de Herder, W. W., Kros, J. M., Del Basso De Caro, M. L., Arvigo, M., Annunziato, L., Lombardi, G., Colao, A., Hofland, L. J., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030837 · Cited by 271
Self-citationSonino, N., & Fava, G. A. (2001) · CNS Drugs · doi:10.2165/00023210-200115050-00003 · Cited by 267
Trainer, P. J., Lawrie, H. S., Verhelst, J., Howlett, T. A., Lowe, D. G., Grossman, A. B., Savage, M. O., Afshar, F., & Besser, G. M. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb00975.x · Cited by 267
Risk factors and long-term outcome in pituitary-dependent Cushing's disease
Sonino, N. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.7.2647 · Cited by 265
LAMBERTS, S. W. J. (1988) · Endocrine Reviews · doi:10.1210/edrv-9-4-417 · Cited by 265
Atkinson, A. B., Kennedy, A., Wiggam, M. I., McCance, D. R., & Sheridan, B. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02380.x · Cited by 263
Pathobiology of Pituitary Adenomas and Carcinomas
Scheithauer, B. W., Gaffey, T. A., Lloyd, R. V., Sebo, T. J., Kovacs, K. T., Horvath, E., Yapcer, Ö., Young, W. F., Meyer, F. B., Kuroki, T., et al. (2006) · Neurosurgery · doi:10.1227/01.neu.0000223437.51435.6e · Cited by 262
Pasireotide Alone or with Cabergoline and Ketoconazole in Cushing's Disease
Feelders, R. A., de Bruin, C., Pereira, A. M., Romijn, J. A., Netea-Maier, R. T., Hermus, A. R., Zelissen, P. M., van Heerebeek, R., de Jong, F. H., van der Lely, A.-J., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmc1000094 · Cited by 262
Sheehan, J. P., Niranjan, A., Sheehan, J. M., Jane, J. A., Laws, E. R., Kondziolka, D., Flickinger, J., Landolt, A. M., Loeffler, J. S., & Lunsford, L. D. (2005) · Journal of Neurosurgery · doi:10.3171/jns.2005.102.4.0678 · Cited by 262
Rees, D. A., Hanna, F. W. F., Davies, J. S., Mills, R. G., Vafidis, J., & Scanlon, M. F. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01511.x · Cited by 261
Gender-Related Differences in the Presentation and Course of Cushing’s Disease
Giraldi, F. P., Moro, M., & Cavagnini, F. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021518 · Cited by 260
Dorn, L. D., Burgess, E. S., Friedman, T. C., Dubbert, B., Gold, P. W., & Chrousos, G. P. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.3.3834 · Cited by 260
Gamma Knife surgery for Cushing's disease
Jagannathan, J., Sheehan, J. P., Pouratian, N., Laws, E. R., Steiner, L., & Vance, M. L. (2007) · Journal of Neurosurgery · doi:10.3171/jns.2007.106.6.980 · Cited by 258
Resistance to Somatostatin Analogs in Acromegaly
Colao, A., Auriemma, R. S., Lombardi, G., & Pivonello, R. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0002 · Cited by 257
Self-citationFeelders, R. A., Pulgar, S. J., Kempel, A., & Pereira, A. M. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-1095 · Cited by 256
EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas
Fukuoka, H., Cooper, O., Ben-Shlomo, A., Mamelak, A., Ren, S.-G., Bruyette, D., & Melmed, S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci60417 · Cited by 254
Quality of Life in Patients after Long-Term Biochemical Cure of Cushing’s Disease
van Aken, M. O., Pereira, A. M., Biermasz, N. R., van Thiel, S. W., Hoftijzer, H. C., Smit, J. W. A., Roelfsema, F., Lamberts, S. W. J., & Romijn, J. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1375 · Cited by 253
LIDDLE, G. W., ISLAND, D., LANCE, E. M., & HARRIS, A. P. (1958) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-18-8-906 · Cited by 249
Neurological complications of radiotherapy and chemotherapy
Keime-Guibert, F., Napolitano, M., & Delattre, J.-Y. (1998) · Journal of Neurology · doi:10.1007/s004150050271 · Cited by 246
Transsphenoidal microsurgical management of Cushing's disease: Report of 100 cases
Boggan, J. E., Tyrrell, J. B., & Wilson, C. B. (1983) · Journal of Neurosurgery · doi:10.3171/jns.1983.59.2.0195 · Cited by 243
Cooney, A. J., Leng, X., Tsai, S. Y., O'Malley, B. W., & Tsai, M. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53592-4 · Cited by 240
Radiation Therapy in the Management of Pituitary Adenomas
Loeffler, J. S., & Shih, H. A. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0251 · Cited by 239
Bourdeau, I. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.5.1949 · Cited by 239
Radiosurgery for Cushing's disease after failed transsphenoidal surgery
Sheehan, J. M., Vance, M. L., Sheehan, J. P., Ellegala, D. B., & Laws, E. R. (2000) · Journal of Neurosurgery · doi:10.3171/jns.2000.93.5.0738 · Cited by 238
COUP orphan receptors are negative regulators of retinoic acid response pathways.
Tran, P., Zhang, X. K., Salbert, G., Hermann, T., Lehmann, J. M., & Pfahl, M. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.10.4666 · Cited by 238
The spectrum of endometrial pathology induced by progesterone receptor modulators
Mutter, G. L., Bergeron, C., Deligdisch, L., Ferenczy, A., Glant, M., Merino, M., Williams, A. R. W., & Blithe, D. L. (2008) · Modern Pathology · doi:10.1038/modpathol.2008.19 · Cited by 236
The New Steroid Analog RU 486 Inhibits Glucocorticoid Action in Man
BERTAGNA, X., BERTAGNA, C., LUTON, J.-P., HUSSON, J.-M., & GIRARD, F. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-1-25 · Cited by 235
Long-Term Mortality after Transsphenoidal Surgery for Cushing Disease
Swearingen, B., Biller, B. M. K., Barker, F. G., Katznelson, L., Grinspoon, S., Klibanski, A., & Zervas, N. T. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-10-199905180-00015 · Cited by 231
Assié, G., Bahurel, H., Coste, J., Silvera, S., Kujas, M., Dugué, M.-A., Karray, F., Dousset, B., Bertherat, J., Legmann, P., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1328 · Cited by 230
Webb, S. M., Badia, X., Barahona, M. J., Colao, A., Strasburger, C. J., Tabarin, A., van Aken, M. O., Pivonello, R., Stalla, G., Lamberts, S. W. J., et al. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0762 · Cited by 229
Self-citationCalhoun, D. A., White, W. B., Krum, H., Guo, W., Bermann, G., Trapani, A., Lefkowitz, M. P., & Ménard, J. (2011) · Circulation · doi:10.1161/circulationaha.111.029892 · Cited by 227
Functional PPAR-γ receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas
Heaney, A. P., Fernando, M., Yong, W. H., & Melmed, S. (2002) · Nature Medicine · doi:10.1038/nm784 · Cited by 226
Dekkers, O. M., Biermasz, N. R., Pereira, A. M., Roelfsema, F., van Aken, M. O., Voormolen, J. H. C., & Romijn, J. A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2112 · Cited by 223
Results of Treating Childhood Cushing's Disease with Pituitary Irradiation
Jennings, A. S., Liddle, G. W., & Orth, D. N. (1977) · New England Journal of Medicine · doi:10.1056/nejm197711032971801 · Cited by 223
Bertagna, X., Guignat, L., Groussin, L., & Bertherat, J. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.06.001 · Cited by 222
Kamenický, P., Droumaguet, C., Salenave, S., Blanchard, A., Jublanc, C., Gautier, J.-F., Brailly-Tabard, S., Leboulleux, S., Schlumberger, M., Baudin, E., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0536 · Cited by 221
Semple, P. L., & Laws, E. R. (1999) · Journal of Neurosurgery · doi:10.3171/jns.1999.91.2.0175 · Cited by 219
Epidemiology of Cushing’s Syndrome
Steffensen, C., Bak, A. M., Zøylner Rubeck, K., & Jørgensen, J. O. L. (2010) · Neuroendocrinology · doi:10.1159/000314297 · Cited by 217
Ketoconazole and Other Imidazole Derivatives as Inhibitors of Steroidogenesis
FELDMAN, D. (1986) · Endocrine Reviews · doi:10.1210/edrv-7-4-409 · Cited by 217
Radiation therapy for pituitary adenoma: Treatment outcome and prognostic factors
Tsang, R. W., Brierley, J. D., Panzarella, T., Gospodarowicz, M. K., Sutcliffe, S. B., & Simpson, W. J. (1994) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(92)90941-a · Cited by 216
Repeat transsphenoidal surgery for Cushing's disease
Friedman, R. B., Oldfield, E. H., Nieman, L. K., Chrousos, G. P., Doppman, J. L., Cutler, G. B., & Loriaux, D. L. (1989) · Journal of Neurosurgery · doi:10.3171/jns.1989.71.4.0520 · Cited by 211
The incidence of cerebrovascular accidents in patients with pituitary adenoma
Brada, M., Burchell, L., Ashley, S., & Traish, D. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00159-5 · Cited by 210
Treatment of Cushing's Disease by o,p′DDD: Survey of 62 Cases
Luton, J. P., Mahoudeau, J. A., Bouchard, P., Thieblot, P., Hautecouverture, M., Simon, D., Laudat, M. H., Touitou, Y., & Bricaire, H. (1979) · New England Journal of Medicine · doi:10.1056/nejm197903013000903 · Cited by 210
Tritos, N. A., Biller, B. M. K., & Swearingen, B. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.12 · Cited by 208
Mitsumori, M., Shrieve, D. C., Alexander, E., Kaiser, U. B., Richardson, G. E., Black, P. M., & Loeffler, J. S. (1998) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(98)00256-9 · Cited by 208
Hofmann, B. M., Hlavac, M., Martinez, R., Buchfelder, M., Müller, O. A., & Fahlbusch, R. (2008) · Journal of Neurosurgery · doi:10.3171/jns/2008/108/01/0009 · Cited by 206
Transsphenoidal Removal of Pituitary Microadenoma in Cushing’s Disease
Salassa, R. M., Laws, E. R., Carpenter, P. C., & Northcutt, R. C. (1978) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(25)38014-6 · Cited by 204
Alexandraki, K. I., Kaltsas, G. A., Isidori, A. M., Storr, H. L., Afshar, F., Sabin, I., Akker, S. A., Chew, S. L., Drake, W. M., Monson, J. P., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-0921 · Cited by 203
Yap, L. B., Turner, H. E., Adams, C. B. T., & Wass, J. A. H. (2002) · Clinical Endocrinology · doi:10.1046/j.0300-0664.2001.01444.x · Cited by 203
Cabergoline monotherapy in the long-term treatment of Cushing's disease
Godbout, A., Manavela, M., Danilowicz, K., Beauregard, H., Bruno, O. D., & Lacroix, A. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0382 · Cited by 202
The Medical Treatment of Cushing's Syndrome
MILLER, J. W., & CRAPO, L. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-4-443 · Cited by 202
Amar, L., Azizi, M., Menard, J., Peyrard, S., Watson, C., & Plouin, P.-F. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.157271 · Cited by 202
Ketoconazole treatment in Cushing’s syndrome: experience in 34 patients
Sonino, N., Boscaro, M., Paoletta, A., Mantero, F., & Zillotto, D. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb03547.x · Cited by 201
Batista, D. L., Zhang, X., Gejman, R., Ansell, P. J., Zhou, Y., Johnson, S. A., Swearingen, B., Hedley-Whyte, E. T., Stratakis, C. A., & Klibanski, A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1245 · Cited by 201
Outcome of Bilateral Adrenalectomy in Cushing's Syndrome: A Systematic Review
Ritzel, K., Beuschlein, F., Mickisch, A., Osswald, A., Schneider, H. J., Schopohl, J., & Reincke, M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1470 · Cited by 201
Successful Long-Term Treatment of Refractory Cushing's Disease with High-Dose Mifepristone (RU 486)
Chu, J. W. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.8.3568 · Cited by 200
Höybye, C., Grenbäck, E., Rähn, T., Degerblad, M., Thorén, M., & Hulting, A.-L. (2001) · Neurosurgery · doi:10.1097/00006123-200108000-00008 · Cited by 200
Anticoagulant Prophylaxis Markedly Reduces Thromboembolic Complications in Cushing's Syndrome
Boscaro, M. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.8.3662 · Cited by 198
Gumbs, A. A., & Gagner, M. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.07.010 · Cited by 197
Pai, H. H., Thornton, A., Katznelson, L., Finkelstein, D. M., Adams, J. A., Fullerton, B. C., Loeffler, J. S., Leibsch, N. J., Klibanski, A., & Munzenrider, J. E. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)01387-0 · Cited by 196
Pivonello, R., De Martino, M. C., De Leo, M., Lombardi, G., & Colao, A. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2007.10.010 · Cited by 195
Self-citationOpportunistic Infections in Endogenous Cushing's Syndrome
GRAHAM, B. S., & TUCKER, W. S. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-3-334 · Cited by 195
Early repeat surgery for persistent Cushing's disease
Ram, Z., Nieman, L. K., Cutler, G. B., Chrousos, G. P., Doppman, J. L., & Oldfield, E. H. (1994) · Journal of Neurosurgery · doi:10.3171/jns.1994.80.1.0037 · Cited by 194
Pollock, B. E., Nippoldt, T. B., Stafford, S. L., Foote, R. L., & Abboud, C. F. (2002) · Journal of Neurosurgery · doi:10.3171/jns.2002.97.3.0525 · Cited by 193
Left ventricular structural and functional characteristics in Cushing’s syndrome
Muiesan, M. L., Lupia, M., Salvetti, M., Grigoletto, C., Sonino, N., Boscaro, M., Rosei, E. A., Mantero, F., & Fallo, F. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00493-5 · Cited by 193
Kline, L. B., Kim, J. Y., & Ceballos, R. (1985) · Ophthalmology · doi:10.1016/s0161-6420(85)33898-8 · Cited by 192
Esposito, F., Dusick, J. R., Cohan, P., Moftakhar, P., McArthur, D., Wang, C., Swerdloff, R. S., & Kelly, D. F. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1204 · Cited by 192
Pathophysiology of Diabetes Mellitus in Cushing’s Syndrome
Pivonello, R., De Leo, M., Vitale, P., Cozzolino, A., Simeoli, C., De Martino, M. C., Lombardi, G., & Colao, A. (2010) · Neuroendocrinology · doi:10.1159/000314319 · Cited by 190
Self-citationRetinoic acid prevents experimental Cushing syndrome
Páez-Pereda, M., Kovalovsky, D., Hopfner, U., Theodoropoulou, M., Pagotto, U., Uhl, E., Losa, M., Stalla, J., Grübler, Y., Missale, C., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11098 · Cited by 190
Bertagna, X., Pivonello, R., Fleseriu, M., Zhang, Y., Robinson, P., Taylor, A., Watson, C. E., Maldonado, M., Hamrahian, A. H., Boscaro, M., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2117 · Cited by 189
Self-citationPathophysiology of Dyslipidemia in Cushing’s Syndrome
Arnaldi, G., Scandali, V. M., Trementino, L., Cardinaletti, M., Appolloni, G., & Boscaro, M. (2010) · Neuroendocrinology · doi:10.1159/000314213 · Cited by 189
Radiation Optic Neuropathy after Stereotactic Radiosurgery
Girkin, C. A., Comey, C. H., Lunsford, L. D., Goodman, M. L., & Kline, L. B. (1997) · Ophthalmology · doi:10.1016/s0161-6420(97)30084-0 · Cited by 189
Efficiency and tolerance of mitotane in Cushing's disease in 76 patients from a single center
Baudry, C., Coste, J., Bou Khalil, R., Silvera, S., Guignat, L., Guibourdenche, J., Abbas, H., Legmann, P., Bertagna, X., & Bertherat, J. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0358 · Cited by 187
LAMBERTS, S. W. J., LANGE, S. A. D., & STEFANKO, S. Z. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-54-2-286 · Cited by 186
Predictors of Mortality and Long-term Outcomes in Treated Cushing's Disease: A Study of 346 Patients
Lambert, J. K., Goldberg, L., Fayngold, S., Kostadinov, J., Post, K. D., & Geer, E. B. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2893 · Cited by 186
Octreotide May Act as A Radioprotective Agent in Acromegaly
Landolt, A. M., Haller, D., Lomax, N., Scheib, S. G., Schubiger, O., Siegfried, J., & Wellis, G. N. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.3.1287 · Cited by 186
Isidori, A. M., Graziadio, C., Paragliola, R. M., Cozzolino, A., Ambrogio, A. G., Colao, A., Corsello, S. M., & Pivonello, R. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000415 · Cited by 185
Self-citationPPAR-γ receptor ligands: novel therapy for pituitary adenomas
Heaney, A. P., Fernando, M., & Melmed, S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16575 · Cited by 184
Transsphenoidal Surgery for Cushing's Disease
Fahlbusch, R., Buchfelder, M., & Müller, O. A. (1986) · Journal of the Royal Society of Medicine · doi:10.1177/014107688607900504 · Cited by 184
Mortality and morbidity in Cushing's syndrome in New Zealand
Bolland, M. J., Holdaway, I. M., Berkeley, J. E., Lim, S., Dransfield, W. J., Conaglen, J. V., Croxson, M. S., Gamble, G. D., Hunt, P. J., & Toomath, R. J. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04124.x · Cited by 182
Transsphenoidal pituitary surgery in Cushing's disease: can we predict outcome?
Chee, G. H., Mathias, D. B., James, R. A., & Kendall‐Taylor, P. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01261.x · Cited by 182
Drug-Drug Interaction Profiles of Proton Pump Inhibitors
Ogawa, R., & Echizen, H. (2010) · Clinical Pharmacokinetics · doi:10.2165/11531320-000000000-00000 · Cited by 179
Second Tumors after Radiosurgery: Tip of the Iceberg or a Bump in the Road?
Loeffler, J. S., Niemierko, A., & Chapman, P. H. (2003) · Neurosurgery · doi:10.1227/01.neu.0000064809.59806.e8 · Cited by 179
Gamma knife radiosurgery is a successful adjunctive treatment in Cushing’s disease
Castinetti, F., Nagai, M., Dufour, H., Kuhn, J.-M., Morange, I., Jaquet, P., Conte-Devolx, B., Regis, J., & Brue, T. (2007) · European Journal of Endocrinology · doi:10.1530/eje.1.02323 · Cited by 175
Ketoconazole revisited: a preoperative or postoperative treatment in Cushing’s disease
Castinetti, F., Morange, I., Jaquet, P., Conte-Devolx, B., & Brue, T. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0514 · Cited by 175
Ragin, A., Baumgartner, C., Pierce, D., & Ciric, I. (1997) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)70812-8 · Cited by 175
The Metabolic Syndrome and Cardiovascular Risk in Cushing's Syndrome
Pivonello, R., Faggiano, A., Lombardi, G., & Colao, A. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.01.010 · Cited by 173
Self-citationNeuropsychiatric Disorders in Cushing’s Syndrome
Pereira, A. M., Tiemensma, J., & Romijn, J. A. (2010) · Neuroendocrinology · doi:10.1159/000314317 · Cited by 173
Pereira, A. M., van Aken, M. O., van Dulken, H., Schutte, P. J., Biermasz, N. R., Smit, J. W. A., Roelfsema, F., & Romijn, J. A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030751 · Cited by 173
Preda, V. A., Sen, J., Karavitaki, N., & Grossman, A. B. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0274 · Cited by 172
Hepatic reactions associated with ketoconazole in the United Kingdom.
Lake-Bakaar, G., Scheuer, P. J., & Sherlock, S. (1987) · BMJ · doi:10.1136/bmj.294.6569.419 · Cited by 171
Effect of Gamma-Aminobutyric Acid (GABA) and GABA Antagonist Drugs on ACTH Release
Makara, G. B., & Stark, E. (1974) · Neuroendocrinology · doi:10.1159/000122564 · Cited by 171
Diagnostic categorization of psychiatric disturbance in Cushing's syndrome
(1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.8.911 · Cited by 171
Physiopathology of Cushing's Disease
KRIEGER, D. T. (1983) · Endocrine Reviews · doi:10.1210/edrv-4-1-22 · Cited by 169
Schmid, H. A., & Schoeffter, P. (2004) · Neuroendocrinology · doi:10.1159/000080741 · Cited by 168
Long-term response of pituitary carcinoma to temozolomide
Fadul, C. E., Kominsky, A. L., Meyer, L. P., Kingman, L. S., Kinlaw, W. B., Rhodes, C. H., Eskey, C. J., & Simmons, N. E. (2006) · Journal of neurosurgery · doi:10.3171/jns.2006.105.4.621 · Cited by 167
Blevins, L. S., Christy, J. H., Khajavi, M., & Tindall, G. T. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.1.4525 · Cited by 167
Jagannathan, J., Smith, R., DeVroom, H. L., Vortmeyer, A. O., Stratakis, C. A., Nieman, L. K., & Oldfield, E. H. (2009) · Journal of Neurosurgery · doi:10.3171/2008.8.jns08339 · Cited by 166
Metyrapone in long-term management of Cushing's disease.
Jeffcoate, W. J., Rees, L. H., Tomlin, S., Jones, A. E., Edwards, C. R., & Besser, G. M. (1977) · BMJ · doi:10.1136/bmj.2.6081.215 · Cited by 165
Merits and pitfalls of mifepristone in Cushing's syndrome
Castinetti, F., Fassnacht, M., Johanssen, S., Terzolo, M., Bouchard, P., Chanson, P., Do Cao, C., Morange, I., Picó, A., Ouzounian, S., et al. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0098 · Cited by 163
Treatment of Cushing's Disease in Childhood and Adolescence by Transsphenoidal Microadenomectomy
Styne, D. M., Grumbach, M. M., Kaplan, S. L., Wilson, C. B., & Conte, F. A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198404053101405 · Cited by 162
Treatment planning for gamma knife radiosurgery with multiple isocenters
Flickinger, J. C., Dade^Lunsford, L., Wu, A., Maitz, A. H., & Kalend, A. M. (1990) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(90)90326-f · Cited by 162
Hypercoagulability in Cushing's syndrome: prevalence, pathogenesis and treatment
van der Pas, R., Leebeek, F. W. G., Hofland, L. J., de Herder, W. W., & Feelders, R. A. (2013) · Clinical Endocrinology · doi:10.1111/cen.12094 · Cited by 162
Radiosurgery for Pituitary Tumors and Craniopharyngiomas
Laws, E. R., & Vance, M. L. (1999) · Neurosurgery Clinics of North America · doi:10.1016/s1042-3680(18)30198-0 · Cited by 161
Outcome of Surgical Treatment of 200 Children With Cushing's Disease
Lonser, R. R., Wind, J. J., Nieman, L. K., Weil, R. J., DeVroom, H. L., & Oldfield, E. H. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3604 · Cited by 160
Delayed Remission after Transsphenoidal Surgery in Patients with Cushing’s Disease
Valassi, E., Biller, B. M. K., Swearingen, B., Pecori Giraldi, F., Losa, M., Mortini, P., Hayden, D., Cavagnini, F., & Klibanski, A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1672 · Cited by 160
Novel insights in dopamine receptor physiology
Pivonello, R., Ferone, D., Lombardi, G., Colao, A., Lamberts, S. W. J., & Hofland, L. J. (2007) · European Journal of Endocrinology · doi:10.1530/eje.1.02353 · Cited by 160
Self-citationSubtle cognitive impairments in patients with long-term cure of Cushing’s disease
Tiemensma, J., Kokshoorn, N. E., Biermasz, N. R., Keijser, B.-J. S. A., Wassenaar, M. J. E., Middelkoop, H. A. M., Pereira, A. M., & Romijn, J. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2032 · Cited by 159
Chen, J. C. T., Amar, A. P., Choi, S., Singer, P., Couldwell, W. T., & Weiss, M. H. (2003) · Journal of Neurosurgery · doi:10.3171/jns.2003.98.5.0967 · Cited by 158
Hypertension in Cushing's syndrome
Magiakou, M. A., Smyrnaki, P., & Chrousos, G. P. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.07.006 · Cited by 158
External radiotherapy of pituitary adenomas
Zierhut, D., Flentje, M., Adolph, J., Erdmann, J., Raue, F., & Wannenmacher, M. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(95)00071-6 · Cited by 158
Medical Treatment of Cushing's Disease
Feelders, R. A., & Hofland, L. J. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3126 · Cited by 158
Colin, P., Jovenin, N., Delemer, B., et al. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.09.058 · Cited by 157
SCHULTE, H. M., BENKER, G., REINWEIN, D., SIPPELL, W. G., & ALLOLIO, B. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-5-1426 · Cited by 156
van der Hoek, J., Waaijers, M., van Koetsveld, P. M., Sprij-Mooij, D. M., Feelders, R. A., SCHMID, H. A., Schoeffter, P., Hoyer, D., Cervia, D., Taylor, J. E., et al. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00004.2005 · Cited by 156
Colao, A., Block, C. E. M. D., Gaztambide, M. S., Kumar, S., Seufert, J., & Casanueva, F. F. (2013) · Pituitary · doi:10.1007/s11102-013-0483-3 · Cited by 156
Self-citation
Research works printed but not linked: 143
- Lüdecke, 1976, Selective removal of hypersecreting pituitary adenomas? An analysis of endocrine function, operative and microscopical findings in 101 cases, Acta Neurochir (Wien), 35, 27, 10.1007/BF01405930 · doi:10.1007/bf01405930
- Carmalt, 1977, The treatment of Cushing's disease by trans-sphenoidal hypophysectomy, Q J Med, 46, 119
- Wajchenberg, 1979, Evaluation of resection of pituitary microadenoma for the treatment of Cushing's disease in patients with radiologically normal sella turcica, Clin Endocrinol (Oxf), 11, 323, 10.1111/j.1365-2265.1979.tb03081.x · doi:10.1111/j.1365-2265.1979.tb03081.x
- Hardy, 1982, Presidential address: XVII Canadian Congress of Neurological Sciences. Cushing's disease: 50 years later, Can J Neurol Sci, 9, 375, 10.1017/S0317167100044279 · doi:10.1017/s0317167100044279
- Thomas, 1983, Long term results of radical hypophysectomy for Cushing's disease, Clin Endocrinol (Oxf), 19, 629, 10.1111/j.1365-2265.1983.tb00041.x · doi:10.1111/j.1365-2265.1983.tb00041.x
- Brand, 1985, Long-term follow up of trans-sphenoidal hypophysectomy for Cushing's disease, J R Soc Med, 78, 291, 10.1177/014107688507800404 · doi:10.1177/014107688507800404
- Tagliaferri, 1986, Transsphenoidal microsurgery for Cushing's disease, Acta Endocrinol (Copenh), 113, 5, 10.1530/acta.0.1130005 · doi:10.1530/acta.0.1130005
- van Aken, 1997, Postoperative metyrapone test in the early assessment of outcome of pituitary surgery for Cushing's disease, Clin Endocrinol (Oxf), 47, 145, 10.1046/j.1365-2265.1997.2541051.x · doi:10.1046/j.1365-2265.1997.2541051.x
- Vignati, 1994, Early postoperative evaluation in patients with Cushing's disease: usefulness of ovine corticotropin-releasing hormone test in the prediction of recurrence of disease, Eur J Endocrinol, 130, 235, 10.1530/eje.0.1300235 · doi:10.1530/eje.0.1300235
- Powell, 2009, Microscope and endoscopic pituitary surgery, Acta Neurochirurgica, 151, 723, 10.1007/s00701-009-0297-2 · doi:10.1007/s00701-009-0297-2
- Ciric, 2002, Transsphenoidal microsurgery, Neurosurgery, 51, 161, 10.1097/00006123-200207000-00023 · doi:10.1097/00006123-200207000-00023
- Ciric, 2006, Transsphenoidal microsurgery: past, present and future, Expert Rev Anticancer Ther, 6, S75, 10.1586/14737140.6.9s.S75 · doi:10.1586/14737140.6.9s.s75
- Cappabianca, 1998, Endoscopic endonasal transsphenoidal approach to the sella: towards functional endoscopic pituitary surgery (FEPS), Minim Invasive Neurosurg, 41, 66, 10.1055/s-2008-1052019 · doi:10.1055/s-2008-1052019
- Cappabianca, 2004, Endoscopic endonasal transsphenoidal surgery, Neurosurgery, 55, 933, 10.1227/01.NEU.0000137330.02549.0D · doi:10.1227/01.neu.0000137330.02549.0d
- Strychowsky, 2011, Purely endoscopic transsphenoidal surgery versus traditional microsurgery for resection of pituitary adenomas: systematic review, J Otolaryngol Head Neck Surg, 40, 175
- Laws, 2014, The transition from microscopic to endoscopic transsphenoidal surgery: the experience at Brigham and Women's Hospital, World Neurosurg, 82, S152, 10.1016/j.wneu.2014.07.035 · doi:10.1016/j.wneu.2014.07.035
- Haddad, 1991, Pediatric pituitary tumors, Neurosurgery, 29, 509, 10.1227/00006123-199110000-00004 · doi:10.1227/00006123-199110000-00004
- Mehrazin, 2007, Pituitary tumors in children: clinical analysis of 21 cases, Childs Nerv Syst, 23, 391, 10.1007/s00381-006-0259-4 · doi:10.1007/s00381-006-0259-4
- Doniach, 1977, Histopathology of the anterior pituitary, Clin Endocrinol Metab, 6, 21, 10.1016/S0300-595X(77)80055-8 · doi:10.1016/s0300-595x(77)80055-8
- Kovács, 2013, ACTH-secreting Crooke cell carcinoma of the pituitary, Eur J Clin Invest, 43, 20, 10.1111/eci.12010 · doi:10.1111/eci.12010
- Felix, 1981, Massive Crooke's hyalinization in corticotroph cell adenomas of the human pituitary. A histological, immunocytological, and electron microscopic study of three cases, Acta Neurochir (Wien), 58, 235, 10.1007/BF01407130 · doi:10.1007/bf01407130
- Jho, 1996, Endoscopy assisted transsphenoidal surgery for pituitary adenoma. Technical note, Acta Neurochir (Wien), 138, 1416, 10.1007/BF01411120 · doi:10.1007/bf01411120
- Cappabianca, 2002, Surgical complications associated with the endoscopic endonasal transsphenoidal approach for pituitary adenomas, J Neurosurg, 97, 293, 10.3171/jns.2002.97.2.0293 · doi:10.3171/jns.2002.97.2.0293
- Zada, 2010, Intraoperative conversion from endoscopic to microscopic approach for the management of sellar pathology: incidence and rationale in a contemporary series, World Neurosurg, 73, 334, 10.1016/j.wneu.2010.02.069 · doi:10.1016/j.wneu.2010.02.069
- Murty, 1990, Early inappropriate secretion of antidiuretic hormone after trans-sphenoidal pituitary adenomectomy, J Laryngol Otol, 104, 894, 10.1017/S0022215100114288 · doi:10.1017/s0022215100114288
- Ultmann, 1992, Transient hyponatremia after damage to the neurohypophyseal tracts, Neuroendocrinology, 56, 803, 10.1159/000126310 · doi:10.1159/000126310
- Levy, 1991, Heavy-charged-particle radiosurgery of the pituitary gland: clinical results of 840 patients, Stereotact Funct Neurosurg, 57, 22, 10.1159/000099553 · doi:10.1159/000099553
- Edmonds, 1972, External irradiation of the hypophysis for Cushing's disease, Can Med Assoc J, 107, 860
- Ahmed, 1984, Treatment of Cushing's disease with low dose radiation therapy, Br Med J Clin Res Ed, 289, 643, 10.1136/bmj.289.6446.643 · doi:10.1136/bmj.289.6446.643
- Vicente, 1991, Results of external pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease, Acta Endocrinol (Copenh), 125, 470, 10.1530/acta.0.1250470 · doi:10.1530/acta.0.1250470
- Grigsby, 1988, Long-term results of radiotherapy in the treatment of pituitary adenomas in children and adolescents, Am J Clin Oncol, 11, 607, 10.1097/00000421-198812000-00001 · doi:10.1097/00000421-198812000-00001
- Degerblad, 1986, Long-term results of stereotactic radiosurgery to the pituitary gland in Cushing's disease, Acta Endocrinol (Copenh), 112, 310, 10.1530/acta.0.1120310 · doi:10.1530/acta.0.1120310
- Ganz, 1993, The effects of Gamma Knife surgery of pituitary adenomas on tumor growth and endocrinopathies. Stereotact, Funct Neurosurg, 61, 30, 10.1159/000100657 · doi:10.1159/000100657
- Inoue, 1999, Pituitary adenomas treated by microsurgery with or without Gamma Knife surgery: experience in 122 cases, Stereotact Funct Neurosurg, 72, 125, 10.1159/000056448 · doi:10.1159/000056448
- Mokry, 1999, A six year experience with the postoperative radiosurgical management of pituitary adenomas, Stereotact Funct Neurosurg, 72, 88, 10.1159/000056444 · doi:10.1159/000056444
- Shin, 2000, Stereotactic radiosurgery for pituitary adenoma invading the cavernous sinus, J Neurosurg, 93, 2, 10.3171/jns.2000.93.supplement_3.0002 · doi:10.3171/jns.2000.93.supplement_3.0002
- Kobayashi, 2002, Gamma knife radiosurgery in the treatment of Cushing disease: long-term results, J Neurosurg, 97, 422, 10.3171/jns.2002.97.supplement_5.0422 · doi:10.3171/jns.2002.97.supplement_5.0422
- Wong, 2003, LINAC radiosurgery in recurrent Cushing's disease after transsphenoidal surgery: a series of 5 cases, Minim Invasive Neurosurg, 46, 327, 10.1055/s-2003-812497 · doi:10.1055/s-2003-812497
- Choi, 2003, Radiological and hormonal responses of functioning pituitary adenomas after gamma knife radiosurgery, Yonsei Med J, 44, 602, 10.3349/ymj.2003.44.4.602 · doi:10.3349/ymj.2003.44.4.602
- Kajiwara, 2005, Image-guided stereotactic radiosurgery with the CyberKnife for pituitary adenomas, Minim Invasive Neurosurg, 48, 91, 10.1055/s-2004-830261 · doi:10.1055/s-2004-830261
- Zeiler, 2013, Gamma knife in the treatment of pituitary adenomas: results of a single center, Can J Neurol Sci, 40, 546, 10.1017/S0317167100014645 · doi:10.1017/s0317167100014645
- Kim, 1999, Gamma Knife radiosurgery for functioning pituitary microadenoma, Stereotact Funct Neurosurg, 72, 119, 10.1159/000056447 · doi:10.1159/000056447
- Landolt, 2000, Gamma knife radiosurgery for prolactinomas, J Neurosurg, 93, 14, 10.3171/jns.2000.93.supplement_3.0014 · doi:10.3171/jns.2000.93.supplement_3.0014
- Aristizabal, 1977, Relationship of time dose factors to tumor control and complications in the treatment of Cushing's disease by irradiation, Int J Radiat Oncol Biol Phys, 2, 47, 10.1016/0360-3016(77)90007-4 · doi:10.1016/0360-3016(77)90007-4
- Chen, 2001, Radiosurgical management of benign cavernous sinus tumors: dose profiles and acute complications, Neurosurgery, 48, 1022
- Ove, 2000, Preservation of visual fields after peri-sellar gamma-knife radiosurgery, Int J Cancer, 90, 343, 10.1002/1097-0215(20001220)90:6<343::AID-IJC6>3.0.CO;2-H · doi:10.1002/1097-0215(20001220)90:6<343::aid-ijc6>3.0.co;2-h
- Mehta, 1993, Cavernous sinus cranial neuropathies: is there a dose-response relationship following radiosurgery?, Int J Radiat Oncol Biol Phys, 27, 477, 10.1016/0360-3016(93)90262-T · doi:10.1016/0360-3016(93)90262-t
- Liu, 2005, Gamma knife radiosurgery for tumors involving the cavernous sinus, Stereotact Funct Neurosurg, 83, 45, 10.1159/000085544 · doi:10.1159/000085544
- Kuo, 2004, Gamma knife radiosurgery for benign cavernous sinus tumors: quantitative analysis of treatment outcomes, Neurosurgery, 54, 1385, 10.1227/01.NEU.0000124750.13721.94 · doi:10.1227/01.neu.0000124750.13721.94
- Lundström, 1976, Atrophy of optic nerve fibres in compression of the chiasm. Degree and distribution of ophthalmoscopic changes, Acta Ophthalmol (Copenh), 54, 623, 10.1111/j.1755-3768.1976.tb01291.x · doi:10.1111/j.1755-3768.1976.tb01291.x
- Abe, 2002, Early palliation of oculomotor nerve palsy following gamma knife radiosurgery for pituitary adenoma, Eur Neurol, 47, 61, 10.1159/000047951 · doi:10.1159/000047951
- Packer, 2002, Radiation-induced neurocognitive decline: the risks and benefits of reducing the amount of whole-brain irradiation, Curr Neurol Neurosci Rep, 2, 131, 10.1007/s11910-002-0021-6 · doi:10.1007/s11910-002-0021-6
- Guinan, 1998, Cognitive effects of pituitary tumours and their treatments: two case studies and an investigation of 90 patients, J Neurol Neurosurg Psychiatry, 65, 870, 10.1136/jnnp.65.6.870 · doi:10.1136/jnnp.65.6.870
- Niranjan, 2009, Neoplastic transformation after radiosurgery or radiotherapy: risk and realities, Otolaryngol Clin North Am, 42, 717, 10.1016/j.otc.2009.04.005 · doi:10.1016/j.otc.2009.04.005
- Jones, 1991, Radiation oncogenesis in relation to the treatment of pituitary tumours, Clin Endocrinol (Oxf), 35, 379, 10.1111/j.1365-2265.1991.tb03554.x · doi:10.1111/j.1365-2265.1991.tb03554.x
- Wu-Chen, 2009, Intracranial malignancies occurring more than 20 years after radiation therapy for pituitary adenoma, J Neuroophthalmol, 29, 289, 10.1097/WNO.0b013e3181b4a1be · doi:10.1097/wno.0b013e3181b4a1be
- Ecemis, 2013, Radiation-associated secondary brain tumors after conventional radiotherapy and radiosurgery, Expert Rev Neurother, 13, 557, 10.1586/ern.13.37 · doi:10.1586/ern.13.37
- Tsukamoto, 1992, Meningioma developed 25 years after radiation therapy for Cushing's disease, Intern Med, 31, 629, 10.2169/internalmedicine.31.629 · doi:10.2169/internalmedicine.31.629
- Sarkar, 2014, Radiation-induced opticochiasmatic glioblastoma multiforme following conventional radiotherapy for Cushing's disease, Br J Neurosurg, 28, 510, 10.3109/02688697.2013.841850 · doi:10.3109/02688697.2013.841850
- Larson, 1993, The radiobiology of radiosurgery, Int J Radiat Oncol Biol Phys, 25, 557, 10.1016/0360-3016(93)90080-F · doi:10.1016/0360-3016(93)90080-f
- Croughs, 1971, Immediate effect of unilateral adrenalectomy followed by external pituitary irradiation on cortisol secretion rate in subjects suffering from pituitary dependent Cushing's syndrome, J Clin Endocrinol Metab, 33, 912, 10.1210/jcem-33-6-912 · doi:10.1210/jcem-33-6-912
- Lamberts, 1977, Evaluation of a therapeutic regimen in Cushing's disease. The predictability of the result of unilateral adrenalectomy followed by external pituitary irradiation, Acta Endocrinol (Copenh), 86, 146, 10.1530/acta.0.0860146 · doi:10.1530/acta.0.0860146
- Landau, 1978, Unilateral adrenalectomy and pituitary irradiation in the treatment of ACTH-dependent Cushing's disease in children and adolescents, Clin Endocrinol (Oxf), 9, 221, 10.1111/j.1365-2265.1978.tb02203.x · doi:10.1111/j.1365-2265.1978.tb02203.x
- Ernest, 1972, Adrenalectomy in Cushing's disease. A long-term follow-up, Acta Endocrinol Suppl (Copenh), 160, 3
- Tomita, 1981, Follow-up study on treatment in 27 patients with Cushing's disease: adrenalectomy, transsphenoidal adenomectomy and medical treatment, Endocrinol Jpn, 28, 197, 10.1507/endocrj1954.28.197 · doi:10.1507/endocrj1954.28.197
- Kelly, 1983, Cushing's disease treated by total adrenalectomy: long-term observations of 43 patients, Q J Med, 52, 224
- Bax, 1996, Laparoscopic bilateral adrenalectomy following failed hypophysectomy, Surg Endosc, 10, 1150, 10.1007/s004649900268 · doi:10.1007/s004649900268
- Chapuis, 1997, Bilateral laparoscopic adrenalectomy for Cushing's disease, Br J Surg, 84, 1009, 10.1002/bjs.1800840731 · doi:10.1002/bjs.1800840731
- Acosta, 1999, Laparoscopic versus open adrenalectomy in Cushing's syndrome and disease, Surgery, 126, 1111, 10.1067/msy.2099.102423 · doi:10.1067/msy.2099.102423
- Mikhail, 2006, Open versus laparoscopic simultaneous bilateral adrenalectomy, Urology, 67, 693, 10.1016/j.urology.2005.10.037 · doi:10.1016/j.urology.2005.10.037
- Bulus, 2013, Comparison of laparoscopic and open adrenalectomy, Acta Chir Belg, 113, 203, 10.1080/00015458.2013.11680912 · doi:10.1080/00015458.2013.11680912
- Munir, 2007, Nelson's syndrome, Arq Bras Endocrinol Metabol, 51, 1392, 10.1590/S0004-27302007000800026 · doi:10.1590/s0004-27302007000800026
- Kasperlik-Załuska, 2006, Nelson's syndrome – 46 years later: clinical experience with 37 patients, Zentralbl Neurochir, 67, 14, 10.1055/s-2006-921430 · doi:10.1055/s-2006-921430
- Xing, 2002, Microsurgical treatment of Nelson's syndrome, Chin Med J Engl, 115, 1150
- Kemink, 2001, Management of Nelson's syndrome: observations in fifteen patients, Clin Endocrinol (Oxf), 54, 45, 10.1046/j.1365-2265.2001.01187.x · doi:10.1046/j.1365-2265.2001.01187.x
- Wolffenbuttel, 1998, Beneficial gamma-knife radiosurgery in a patient with Nelson's syndrome, Clin Neurol Neurosurg, 100, 60, 10.1016/S0303-8467(97)00124-8 · doi:10.1016/s0303-8467(97)00124-8
- Moore, 1976, Nelson's syndrome: frequency, prognosis, and effect of prior pituitary irradiation, Ann Intern Med, 85, 731, 10.7326/0003-4819-85-6-731 · doi:10.7326/0003-4819-85-6-731
- Vik-Mo, 2009, Gamma knife stereotactic radiosurgery of Nelson syndrome, Eur J Endocrinol, 160, 143, 10.1530/EJE-08-0687 · doi:10.1530/eje-08-0687
- Gil-Cárdenas, 2007, Nelson's syndrome after bilateral adrenalectomy for Cushing's disease, Surgery, 141, 147, 10.1016/j.surg.2006.12.003 · doi:10.1016/j.surg.2006.12.003
- Kreutzer, 2009, No effect of the PPAR-γ agonist rosiglitazone on ACTH or cortisol secretion in Nelson's syndrome and Cushing's disease in vitro and in vivo, Clin Neuropathol, 28, 430
- Moyes, 2009, Treatment of Nelson's syndrome with temozolomide, Eur J Endocrinol, 160, 115, 10.1530/EJE-08-0557 · doi:10.1530/eje-08-0557
- Berselli, 1987, Effect of ketoconazole on CRH-induced ACTH and cortisol release in patients with Cushing's disease, Horm Metab Res Suppl, 16, 58
- Tabarin, 1990, Efficacy and long-term tolerance of ketoconazole in the treatment of Cushing's disease [in French], Ann Endocrinol (Paris), 51, 27
- Manavela, 2001, The association of Cushing's disease and primary empty sella turcica, Pituitary, 4, 145, 10.1023/A:1015310806063 · doi:10.1023/a:1015310806063
- Kazy, 2005, Population-based case-control study of oral ketoconazole treatment for birth outcomes, Congenit Anom (Kyoto), 45, 5, 10.1111/j.1741-4520.2005.00053.x · doi:10.1111/j.1741-4520.2005.00053.x
- Chart, 1958, New amphenone analogs as adrenocortical inhibitors, Experientia, 14, 151, 10.1007/BF02157133 · doi:10.1007/bf02157133
- Dewis, 1983, Experience with trilostane in the treatment of Cushing's syndrome, Clin Endocrinol (Oxf), 18, 533, 10.1111/j.1365-2265.1983.tb00590.x · doi:10.1111/j.1365-2265.1983.tb00590.x
- Doenicke, 1994, A comparison of two formulations for etomidate, 2-hydroxypropyl-β-cyclodextrin (HPCD) and propylene glycol, Anesth Analg, 79, 933, 10.1213/00000539-199411000-00020 · doi:10.1213/00000539-199411000-00020
- Zacharias, 1979, Venous sequelae following etomidate, Br J Anaesth, 51, 779, 10.1093/bja/51.8.779 · doi:10.1093/bja/51.8.779
- Doenicke, 1997, Haemolysis after etomidate: comparison of propylene glycol and lipid formulations, Br J Anaesth, 79, 386, 10.1093/bja/79.3.386 · doi:10.1093/bja/79.3.386
- Yorgin, 1997, Propylene glycol-induced proximal renal tubular cell injury, Am J Kidney Dis, 30, 134, 10.1016/S0272-6386(97)90577-1 · doi:10.1016/s0272-6386(97)90577-1
- Hart, 1971, Studies on the site of action of o,p'-DDD in the dog adrenal cortex. 1. Inhibition of ACTH-mediated pregnenolone synthesis, Steroids, 17, 559, 10.1016/S0039-128X(71)80157-5 · doi:10.1016/s0039-128x(71)80157-5
- Southren, 1961, Effect of o,p'DDD in a patient with Cushing's syndrome, J Clin Endocrinol Metab, 21, 201, 10.1210/jcem-21-2-201 · doi:10.1210/jcem-21-2-201
- Dickerman, 1979, Successful treatment of Cushing's disease with o,p'-DDD followed by pituitary irradiation in a 19-year-old male patient, Isr J Med Sci, 15, 455
- Takamatsu, 1981, Does mitotane reduce endogenous ACTH secretion?, N Engl J Med, 305, 957, 10.1056/NEJM198110153051617 · doi:10.1056/nejm198110153051617
- Suda, 1983, Effects of cyproheptadine, reserpine, and synthetic corticotropin-releasing factor on pituitary glands from patients with Cushing's disease, J Clin Endocrinol Metab, 56, 1094, 10.1210/jcem-56-6-1094 · doi:10.1210/jcem-56-6-1094
- Plonk, 1976, Modification of adrenal function by the anti-serotonin agent cyproheptadine, J Clin Endocrinol Metab, 42, 291, 10.1210/jcem-42-2-291 · doi:10.1210/jcem-42-2-291
- Kriegert, 1976, Letter: cyproheptadine for pituitary disorders, N Engl J Med, 295, 394, 10.1056/NEJM197608122950715 · doi:10.1056/nejm197608122950715
- Ambrosi, 1979, Lack of effect of antiserotoninergic and/or dopaminergic treatment in patients with pituitary-dependent Cushing's syndrome, Horm Metab Res, 11, 318, 10.1055/s-0028-1095778 · doi:10.1055/s-0028-1095778
- Tyrrell, 1976, More on cyproheptadine, N Engl J Med, 295, 1137, 10.1056/NEJM197611112952017 · doi:10.1056/nejm197611112952017
- Copinschi, 1977, Lack of effect of cyproheptadine in Cushing's disease and in Nelson's syndrome, Acta Endocrinol (Copenh), 312
- Koppeschaar, 1983, Sodium valproate and cyproheptadine may independently induce a remission in the same patient with Cushing's disease, Acta Endocrinol (Copenh), 104, 160, 10.1530/acta.0.1040160 · doi:10.1530/acta.0.1040160
- Tucci, 1989, Cyproheptadine may act at the pituitary in Cushing's disease: evidence from CRF stimulation, J Endocrinol Invest, 12, 197, 10.1007/BF03349961 · DOI
- Hsu, 1981, Cyproheptadine in the control of Cushing's disease, Johns Hopkins Med J, 149, 77
- Barnes, 1977, Cushing's disease: successful treatment with cyproheptadine, Lancet, 1, 1148, 10.1016/S0140-6736(77)92402-3 · doi:10.1016/s0140-6736(77)92402-3
- Ooi, 1987, Rebound elevation of cortisol following cyproheptadine withdrawal in Cushing's disease from a pituitary macroadenoma, J Endocrinol Invest, 10, 107, 10.1007/BF03347166 · doi:10.1007/bf03347166
- Middler, 1976, Letter: cyproheptadine for pituitary disorders, N Engl J Med, 295, 394, 10.1056/NEJM197608122950715 · doi:10.1056/nejm197608122950715
- Ferrari, 1977, More on cyproheptadine in Cushing's disease, N Engl J Med, 296, 576, 10.1056/NEJM197703102961022 · doi:10.1056/nejm197703102961022
- Grant, 1979, Cushing's disease presenting with growth failure: clinical remission during cyproheptadine therapy, Arch Dis Child, 54, 466, 10.1136/adc.54.6.466 · doi:10.1136/adc.54.6.466
- Pearce, 1977, Treatment of Cushing's disease with cyproheptadine, Lancet, 1, 1368, 10.1016/S0140-6736(77)92585-5 · doi:10.1016/s0140-6736(77)92585-5
- Allgrove, 1977, Cushing's disease: failure of treatment with cyproheptadine, Br Med J, 1, 686, 10.1136/bmj.1.6062.686-a · doi:10.1136/bmj.1.6062.686-a
- D'Ercole, 1977, Treatment of Cushing disease in childhood with cyproheptadine, J Pediatr, 90, 834, 10.1016/S0022-3476(77)81265-1 · doi:10.1016/s0022-3476(77)81265-1
- Kritzler, 1983, Sodium valproate and corticotropin suppression in the child treated for seizures, J Pediatr, 102, 142, 10.1016/S0022-3476(83)80313-8 · doi:10.1016/s0022-3476(83)80313-8
- Koppeschaar, 1982, Sodium valproate and heterogeneity of pituitary dependent Cushing's syndrome, Lancet, 1, 1253, 10.1016/S0140-6736(82)92383-2 · doi:10.1016/s0140-6736(82)92383-2
- Koppeschaar, 1984, Successful treatment with sodium valproate of a patient with Cushing's disease and gross enlargement of the pituitary, Acta Endocrinol (Copenh), 107, 471, 10.1530/acta.0.1070471 · doi:10.1530/acta.0.1070471
- Cavagnini, 1984, Sodium valproate in Cushing's disease, Lancet, 2, 162, 10.1016/S0140-6736(84)91074-2 · doi:10.1016/s0140-6736(84)91074-2
- Ambrosi, 1983, Effects of sodium-valproate administration on plasma ACTH levels in patients with ACTH hypersecretion, J Endocrinol Invest, 6, 305, 10.1007/BF03347595 · doi:10.1007/bf03347595
- Reincke, 1988, The effect of sodium valproate in Cushing's disease, Nelson's syndrome and Addison's disease, Klin Wochenschr, 66, 686, 10.1007/BF01726927 · doi:10.1007/bf01726927
- Loli, 1984, Lack of ACTH lowering effect of sodium valproate in patients with ACTH hypersecretion, J Endocrinol Invest, 7, 93, 10.1007/BF03348396 · doi:10.1007/bf03348396
- Allolio, 1982, Valproate in Cushing's syndrome, Lancet, 1, 171, 10.1016/S0140-6736(82)90422-6 · doi:10.1016/s0140-6736(82)90422-6
- Koppeschaar, 1986, Response to neurotransmitter modulating drugs in patients with Cushing's disease, Clin Endocrinol (Oxf), 25, 661, 10.1111/j.1365-2265.1986.tb03621.x · doi:10.1111/j.1365-2265.1986.tb03621.x
- Beckers, 1990, Cyclical Cushing's disease and its successful control under sodium valproate, J Endocrinol Invest, 13, 923, 10.1007/BF03349657 · doi:10.1007/bf03349657
- Nussey, 1988, The combined use of sodium valproate and metyrapone in the treatment of Cushing's syndrome, Clin Endocrinol (Oxf), 28, 373, 10.1111/j.1365-2265.1988.tb03668.x · doi:10.1111/j.1365-2265.1988.tb03668.x
- Ferone, 2007, Preclinical and clinical experiences with the role of dopamine receptors in the treatment of pituitary adenomas, Eur J Endocrinol, 156, S37, 10.1530/eje.1.02351 · doi:10.1530/eje.1.02351
- Nobels, 2000, Long-term treatment with the dopamine agonist quinagolide of patients with clinically non-functioning pituitary adenoma, Eur J Endocrinol, 143, 615, 10.1530/eje.0.1430615 · doi:10.1530/eje.0.1430615
- Greenman, 2005, Postoperative treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists decreases tumour remnant growth, Clin Endocrinol (Oxf), 63, 39, 10.1111/j.1365-2265.2005.02295.x · doi:10.1111/j.1365-2265.2005.02295.x
- Pirker, 1996, Dopamine D2 receptor imaging in pituitary adenomas using iodine-123-epidepride and SPECT, J Nucl Med, 37, 1931
- Adams, 1981, Bromocriptine suppresses ACTH secretion from human pituitary tumour cells in culture by a dopaminergic mechanism, Clin Endocrinol (Oxf), 15, 479, 10.1111/j.1365-2265.1981.tb00691.x · doi:10.1111/j.1365-2265.1981.tb00691.x
- Yin, 1994, Induction of apoptosis in murine ACTH-secreting pituitary adenoma cells by bromocriptine, FEBS Lett, 339, 73, 10.1016/0014-5793(94)80387-0 · DOI
- Lamberts, 1977, The role of dopaminergic depletion in the pathogenesis of Cushing's disease and the possible consequences for medical therapy, Clin Endocrinol (Oxf), 7, 185, 10.1111/j.1365-2265.1977.tb01314.x · doi:10.1111/j.1365-2265.1977.tb01314.x
- Adachi, 1996, Cyclic Cushing's disease in long-term remission with a daily low dose of bromocriptine, Intern Med, 35, 207, 10.2169/internalmedicine.35.207 · doi:10.2169/internalmedicine.35.207
- McNicol, 1986, A study of corticotroph adenomas in Cushing's disease: no evidence of intermediate lobe origin, Clin Endocrinol (Oxf), 24, 715, 10.1111/j.1365-2265.1986.tb01668.x · doi:10.1111/j.1365-2265.1986.tb01668.x
- Meij, 2000, Double pituitary lesions in three patients with Cushing's disease, Pituitary, 3, 159, 10.1023/A:1011499609096 · doi:10.1023/a:1011499609096
- Nielsen, 2001, Expression of somatostatin receptors on human pituitary adenomas in vivo and ex vivo, J Endocrinol Invest, 24, 430, 10.1007/BF03351043 · doi:10.1007/bf03351043
- Pivonello, 2003, Role of somatostatin analogs in the management of non-functioning neuroendocrine tumors, J Endocrinol Invest, 26, 82
- Invitti, 1991, Effect of sandostatin on CRF-stimulated secretion of ACTH, β-lipotropin and β-endorphin, Horm Metab Res, 23, 233, 10.1055/s-2007-1003660 · doi:10.1055/s-2007-1003660
- Julesz, 1980, Effects of somatostatin and bromocryptine on the plasma ACTH level in bilaterally adrenalectomized patients with Cushing's disease, Endokrinologie, 76, 68
- Kraus, 1999, Regulation of mouse somatostatin receptor type 2 gene expression by glucocorticoids, FEBS Lett, 459, 200, 10.1016/S0014-5793(99)01236-3 · doi:10.1016/s0014-5793(99)01236-3
- Ruan, 2006, SOM230 inhibits insulin-like growth factor-I action in mammary gland development by pituitary independent mechanism: mediated through somatostatin subtype receptor 3?, Mol Endocrinol, 20, 426, 10.1210/me.2005-0283 · DOI
- Lacroix, 2012, Medical treatment of Cushing's disease with pasireotide, Eur J Endocrinol, 8, 99, 10.17925/EE.2012.08.02.99 · doi:10.17925/ee.2012.08.02.99
- Cukier, 2009, Significant response to pasireotide (SOM230) in the treatment of a patient with persistent, refractory Cushing's disease, Clin Endocrinol (Oxf), 71, 305, 10.1111/j.1365-2265.2008.03486.x · doi:10.1111/j.1365-2265.2008.03486.x
- Culler, 2011, Somatostatin-dopamine chimeras: a novel approach to treatment of neuroendocrine tumors, Horm Metab Res, 43, 854, 10.1055/s-0031-1287769 · doi:10.1055/s-0031-1287769
- Colao, 2010, Pituitary carcinomas, Front Horm Res, 38, 94, 10.1159/000318499 · doi:10.1159/000318499
Cited by
Consensus on diagnosis and management of Cushing's disease: a guideline update
Fleseriu, M., Auchus, R., Bancos, I., Ben-Shlomo, A., Bertherat, J., Biermasz, N. R., Boguszewski, C. L., Bronstein, M. D., Buchfelder, M., Carmichael, J. D., et al. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00235-7 · Cited by 953
Self-citationComplications of Cushing's syndrome: state of the art
Pivonello, R., Isidori, A. M., De Martino, M. C., Newell-Price, J., Biller, B. M. K., & Colao, A. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)00086-3 · Cited by 641
Self-citationReincke, M., & Fleseriu, M. (2023) · JAMA · doi:10.1001/jama.2023.11305 · Cited by 256
Pivonello, R., Fleseriu, M., Newell-Price, J., Bertagna, X., Findling, J., Shimatsu, A., Gu, F., Auchus, R., Leelawattana, R., Lee, E. J., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30240-0 · Cited by 222
Self-citationClayton, R. N., Jones, P. W., Reulen, R. C., Stewart, P. M., Hassan-Smith, Z. K., Ntali, G., Karavitaki, N., Dekkers, O. M., Pereira, A. M., Bolland, M., et al. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30005-5 · Cited by 208
Metadata
- Authors
- Pivonello, R., De Leo, M., Cozzolino, A., & Colao, A.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2015-08-01
- Volume
- 36
- Issue
- 4
- Pages
- 385-486
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W1910274646
- Cited by
- 465
- References
- 641
- FWCI
- 27.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.